Aton Stock

Aton Equity

The The Equity of Aton (ALTAO.PA) as of Aug 10, 2026 is 791,000.00 EUR. In the previous year, The Equity was -2.10 M EUR — a change of -137.72% (higher).

Equity

791,000.00EUR

YoY

-137.72%

Last updated:

In 2026, Aton's equity was 791,000.00 EUR, a -137.72% increase from the -2.10 M EUR equity in the previous year.

Access this data via the Eulerpool API

Aton Stock analysis

What does Aton do? Hybrigenics SA is a French company that was founded in 1997 to develop innovative technologies for the discovery and development of new drugs. The company specializes in the identification of proteins responsible for the development of cancer and other diseases, as well as the development of therapies for these diseases. It is headquartered in Paris and has branches in the United States and Japan. Hybrigenics has become a leading provider of protein research technologies since its founding, employing approximately 50 employees including scientists, engineers, and technicians. The company's business model is based on developing innovative technologies for drug discovery and development. It conducts research and development in the field of protein research, particularly protein interaction analysis. The company aims to better understand the mechanism of action of proteins involved in disease development in order to develop targeted therapies. Hybrigenics collaborates closely with its customers to develop tailored solutions for their specific research needs. It provides a range of products and services including proteomic services, screening tools, data analysis software, and platform technologies. The company is divided into different divisions, including proteomic services, screening tools, data analysis software, and platform technologies. Some of the key divisions include proteomic services, which offer customers proteomic services based on decades of experience in protein research and analysis. These services allow customers to identify new proteins involved in specific diseases and also provide protein interaction analysis services to better understand the mechanism of action of disease proteins. Hybrigenics offers screening tools that allow customers to quickly and easily investigate and compare different proteins. These tools are particularly useful for identifying proteins that can serve as indicators for specific diseases. The company also offers data analysis software that enables customers to quickly and accurately evaluate the results of their protein research. This software uses algorithms and artificial intelligence to analyze data and identify patterns. Hybrigenics has also developed a range of platform technologies to help customers optimize their protein research. These technologies include the yeast two-hybrid assay, which can be used to study protein interactions, as well as various technologies for protein expression and purification. Hybrigenics offers a variety of products tailored to its different divisions. Some of the key products include the PIII-Toolbox, a comprehensive platform technology for protein research that allows for fast and efficient identification of protein-protein interactions, HybriScreen Plus, a screening tool that helps customers quickly and easily investigate and compare different proteins, and the yeast two-hybrid assay, a platform technology for studying protein interactions to better understand the mechanism of action of disease proteins. Aton is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Aton's Equity

Aton's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Aton's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Aton's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Aton's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Aton’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Aton stock

The Equity of Aton is 791,000.00 EUR in 2026.

The Equity of Aton changed from -2.10 M EUR to 791,000.00 EUR, representing a -137.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Aton since 2006 – with annual values, charts, and detailed analysis.

The Equity's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Aton historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Aton

All Key Metrics — Aton